No Data
No Data
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $19
SI-Bone: Capitalizing on Market Weakness Amid Favorable Medicare Payment Analysis
SI-BONE Down Over 15%, on Pace for Largest Percent Decrease Since November 2022 -- Data Talk
Express News | SI-BONE Shares Are Trading Lower After the Company Reported Mixed Q3 Financial Results and Narrowed Its FY24 Revenue Guidance
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $18
No Data
No Data